PFE Pfizer Inc.

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

NEW YORK--(BUSINESS WIRE)--

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Mikael Dolsten, President, Worldwide Research and Development, at the Citi 2016 Global Healthcare Conference on Thursday, December 8, 2016 at 2:10 p.m. Eastern Standard Time.

To view and listen to the webcast, visit our web site at www.pfizer.com and click on the “Citi 2016 Global Healthcare Conference” link in the For Investors section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today.

Visitors will be able to view and listen to an archived copy of the webcast at www.pfizer.com.

EN
01/12/2016

Underlying

PFEPfizer Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pfizer Inc.

PFE PFIZER INC.

Pfizer Inc. - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

12/08/25 December 8, 2025 1 EN
EUR 151.63
PFE PFIZER INC.

Moody's Ratings assigns A2 rating to Pfizer's notes; outlook stable

Moody's Ratings (Moody's) assigned a A2 rating to the new senior unsecured notes offering of Pfizer Inc. (Pfizer). There are no changes to Pfizer's existing ratings including the A2 long-term issuer rating, the A2 senior unsecured notes, the A2 senior unsecured revolving credit facility, or the Prim...

11/18/25 November 18, 2025 1 EN
PFE PFIZER INC.

Pfizer Inc.: Update to credit analysis

Our credit view of this issuer reflects its good scale, diversity and pipeline opportunities, weighed against its large patent exposures towards the end of the decade.

10/27/25 October 27, 2025 1 EN
Gary Brode
  • Gary Brode
LLY ELI LILLY AND COMPANY
BMY BRISTOL-MYERS SQUIBB COMPANY
PFE PFIZER INC.
10/06/25 October 6, 2025 1 EN
EUR 151.63
PFE PFIZER INC.

Moody's Ratings assigns A2 rating to Pfizer's subsidiary notes offerin...

Moody's Ratings ("Moody's") assigned a A2 rating to the proposed euro-denominated senior unsecured notes offering by Pfizer Netherlands International Finance B.V. (PNIF BV), a wholly-owned subsidiary of Pfizer Inc. (Pfizer). We also assigned a stable outlook to PNIF BV. The A2 rating assigned to P...

05/14/25 May 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch